chr12-6944473-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP6BS1
The NM_138425.4(C12orf57):c.53-3C>T variant causes a splice region, intron change. The variant allele was found at a frequency of 0.000127 in 1,611,438 control chromosomes in the GnomAD database, including 1 homozygotes. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00011 ( 1 hom. )
Consequence
C12orf57
NM_138425.4 splice_region, intron
NM_138425.4 splice_region, intron
Scores
2
Splicing: ADA: 0.9935
1
1
Clinical Significance
Conservation
PhyloP100: 4.08
Genes affected
C12orf57 (HGNC:29521): (chromosome 12 open reading frame 57) This gene is ubiquitously expressed in human tissues. It is required for development of the human corpus callosum. Mutations in this gene are associated with Temtamy syndrome (TEMTYS). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 12-6944473-C-T is Benign according to our data. Variant chr12-6944473-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 466310.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000256 (39/152390) while in subpopulation AMR AF= 0.00222 (34/15308). AF 95% confidence interval is 0.00163. There are 0 homozygotes in gnomad4. There are 19 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C12orf57 | NM_138425.4 | c.53-3C>T | splice_region_variant, intron_variant | ENST00000229281.6 | NP_612434.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C12orf57 | ENST00000229281.6 | c.53-3C>T | splice_region_variant, intron_variant | 1 | NM_138425.4 | ENSP00000229281.5 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152272Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
39
AN:
152272
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000352 AC: 87AN: 247104Hom.: 0 AF XY: 0.000276 AC XY: 37AN XY: 134058
GnomAD3 exomes
AF:
AC:
87
AN:
247104
Hom.:
AF XY:
AC XY:
37
AN XY:
134058
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000114 AC: 166AN: 1459048Hom.: 1 Cov.: 32 AF XY: 0.0000951 AC XY: 69AN XY: 725748
GnomAD4 exome
AF:
AC:
166
AN:
1459048
Hom.:
Cov.:
32
AF XY:
AC XY:
69
AN XY:
725748
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000256 AC: 39AN: 152390Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74524
GnomAD4 genome
AF:
AC:
39
AN:
152390
Hom.:
Cov.:
33
AF XY:
AC XY:
19
AN XY:
74524
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2024 | In silico analysis indicates that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge - |
Temtamy syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at